GRANULES INDIA Financial Statement Analysis
|
||
|
The Revenues of GRANULES INDIA have decreased by -0.55% YoY .
The Earnings Per Share (EPS) of GRANULES INDIA has increased by 23.68 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
GRANULES INDIA Last 5 Annual Financial Results
[BOM: 532482|NSE : GRANULES]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹4,482 Cr | ₹4,506 Cr | ₹4,512 Cr | ₹3,765 Cr | ₹3,238 Cr |
| Expenses | ₹3,536 Cr | ₹3,650 Cr | ₹3,599 Cr | ₹3,043 Cr | ₹2,382 Cr |
| Operating Profit (Excl OI) | ₹945 Cr | ₹856 Cr | ₹913 Cr | ₹722 Cr | ₹855 Cr |
| Other Income | ₹13 Cr | ₹4.40 Cr | ₹14 Cr | ₹18 Cr | ₹27 Cr |
| Interest | ₹103 Cr | ₹106 Cr | ₹56 Cr | ₹23 Cr | ₹26 Cr |
| Depreciation | ₹226 Cr | ₹207 Cr | ₹184 Cr | ₹159 Cr | ₹151 Cr |
| Profit Before Tax | ₹660 Cr | ₹547 Cr | ₹687 Cr | ₹558 Cr | ₹704 Cr |
| Profit After Tax | ₹502 Cr | ₹405 Cr | ₹517 Cr | ₹413 Cr | ₹549 Cr |
| Consolidated Net Profit | ₹502 Cr | ₹405 Cr | ₹517 Cr | ₹413 Cr | ₹549 Cr |
| Earnings Per Share (Rs) | ₹20.68 | ₹16.72 | ₹21.34 | ₹16.64 | ₹22.18 |
| PAT Margin (%) | 6.73 | 6.19 | 11.45 | 10.96 | 13.91 |
| ROE(%) | 14.52 | 13.46 | 19.18 | 17.49 | 27.64 |
| ROCE(%) | 16.16 | 15.66 | 19.63 | 17.37 | 25.42 |
| Total Debt/Equity(x) | 0.35 | 0.38 | 0.38 | 0.43 | 0.39 |
Key Financials |
||
| Market Cap | : | ₹ 11,551.4 Cr |
| Revenue (TTM) | : | ₹ 4,481.6 Cr |
| Net Profit(TTM) | : | ₹ 501.5 Cr |
| EPS (TTM) | : | ₹ 20.7 |
| P/E (TTM) | : | 23.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GRANULES INDIA | -4% | -3.6% | -9.7% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 1.3% | 5% |
| DIVIS LABORATORIES | -1.7% | 0.5% | 47.2% |
| CIPLA | 0.4% | -1.5% | -1.6% |
| TORRENT PHARMACEUTICALS | -0.2% | 9% | 13.3% |
| DR REDDYS LABORATORIES | 0.5% | -5.7% | -9.1% |
| MANKIND PHARMA | -2.5% | 12.1% | 25% |
| ZYDUS LIFESCIENCES | -0.4% | -0.4% | -16.2% |
| LUPIN | 0.7% | 0.4% | 6.7% |
GRANULES INDIA Revenues
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | -0.55 % |
| 5 Yr CAGR | 8.47 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,482 Cr | -0.55 | |
| Mar2024 | ₹4,506 Cr | -0.12 | |
| Mar2023 | ₹4,512 Cr | 19.84 | |
| Mar2022 | ₹3,765 Cr | 16.29 | |
| Mar2021 | ₹3,238 Cr | - | |
GRANULES INDIA Operating Profit
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | 10.43 % |
| 5 Yr CAGR | 2.53 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹945 Cr | 10.43 | |
| Mar2024 | ₹856 Cr | -6.28 | |
| Mar2023 | ₹913 Cr | 26.56 | |
| Mar2022 | ₹722 Cr | -15.62 | |
| Mar2021 | ₹855 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 11.06 % |
| 5 Yr CAGR | -5.48 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 21.09% | 11.06 | |
| Mar2024 | 18.99% | -6.18 | |
| Mar2023 | 20.24% | 5.58 | |
| Mar2022 | 19.17% | -27.44 | |
| Mar2021 | 26.42% | - | |
GRANULES INDIA Profit After Tax
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | 23.74 % |
| 5 Yr CAGR | -2.26 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹502 Cr | 23.74 | |
| Mar2024 | ₹405 Cr | -21.54 | |
| Mar2023 | ₹517 Cr | 25.16 | |
| Mar2022 | ₹413 Cr | -24.88 | |
| Mar2021 | ₹549 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 8.72 % |
| 5 Yr CAGR | -16.60 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 6.73 % | 8.72 | |
| Mar2024 | 6.19 % | -45.94 | |
| Mar2023 | 11.45 % | 4.47 | |
| Mar2022 | 10.96 % | -21.21 | |
| Mar2021 | 13.91 % | - | |
GRANULES INDIA Earnings Per Share (EPS)
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | 23.68 % |
| 5 Yr CAGR | -1.74 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹21 | 23.68 | |
| Mar2024 | ₹17 | -21.65 | |
| Mar2023 | ₹21 | 28.25 | |
| Mar2022 | ₹17 | -24.98 | |
| Mar2021 | ₹22 | - | |
GRANULES INDIA Return on Capital Employed (ROCE)
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | 3.19 % |
| 5 Yr CAGR | -10.71 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 16.16% | 3.19 | |
| Mar2024 | 15.66% | -20.22 | |
| Mar2023 | 19.63% | 13.01 | |
| Mar2022 | 17.37% | -31.67 | |
| Mar2021 | 25.42% | - | |
GRANULES INDIA Share Price vs Sensex
| Current Share Price | : | ₹476.2 |
| Current MarketCap | : | ₹ 11,551.4 Cr |
| Updated EOD on | : | Jul 24,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -4% |
-3.6% |
-9.7% |
| SENSEX | -0.1% |
0.2% |
2.1% |
GRANULES INDIA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE HEALTHCARE | -0.4% | 5% | 17.5% |
| BSE 500 | -0.5% | 0.9% | 0.9% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MIDSMALL HEALTHCARE | 0.2% | 8.6% | 22.7% |
| NIFTY HEALTHCARE INDEX | -0.1% | 4.4% | 12.5% |
| NIFTY 500 | -0.5% | 0.8% | 1.6% |
| NIFTY TOTAL MARKET | -0.5% | 1% | 1.7% |
| NIFTY PHARMA | -0.6% | 4% | 9.2% |
You may also like the below Video Courses
FAQ about GRANULES INDIA Financials
How the annual revenues of GRANULES INDIA have changed ?
The Revenues of GRANULES INDIA have decreased by -0.55% YoY .
How the Earnings per Share (EPS) of GRANULES INDIA have changed?
The Earnings Per Share (EPS) of GRANULES INDIA has increased by 23.68 % YoY .
Check out Intrinsic Value of Peers of GRANULES INDIA
Compare Stock Analytics of Peers of GRANULES INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
